Michael A Diefenbach entered the industry of Medical Research in 2004 and has grown to employ 1 to 4 people, generating an annual revenue of $0 to $49.999. The NAICS classifies this business under the code 541720, which describes it as a Medical Research. For further clarification, the SIC classifies this business under the code 8733 and described it as a Medical Research. The business provides service to the B2B market.
To acquire more information, please contact Michael Diefenbach by calling (212) 280-4111 during business hours. You can also write to the business’ Single Location at 924 West End Avenue Apartment 95, New York City, New York NY 10025. You can also visit the company’s website at . View this business’ social media profiles on Twitter or on Facebbok .
| Company: | Michael A Diefenbach |
| Representative: | Michael Diefenbach |
| Place of Business: | 924 West End Avenue Apartment 95, New York City, NY 10025 |
| Contact Number: | (212) 280-4111 |
| Type of Service: | Medical Research |
| SIC Number: | 8733 |
| NAICS Number: | 541720 |
| Locality: | Single Location |
| Market Type: | B2B (Business to Business) |
| Began: | 2004 |
| Income/Year: | $0 to $49.999 |
| Laborers: | 1 to 4 |
| Share This Company: |
Michael A Diefenbach is a company operating from New York, New York providing professional Medical Research and relevant B2B variables. It was founded in 2004 and registered with the SIC code 8733 as Medical Research, and with the NAICS code 541720 as Medical Research.
With a current employee count of 1 to 4, Michael A Diefenbach has gone to report making $0 to $49.999 per annum on its journey towards growth. This company invites you to contact its representative Michael Diefenbach at (212) 280-4111 for related queries, or to locate its Single Location using the coordinates 40.801113,-73.968728.
The Single Location can also be found at the street address 924 West End Avenue Apartment 95 in New York City, New York 10025 and can be engaged online through the company website at , the company Twitter , and Facebook page .